So who do we believe? The anonymous penny a post boiler room trolls haunting this mb in unwashed sweatpants and their so very transparent disingenuity . Or, lets see, we have a highly educated professional biotech industry analyst who has signed his real name to his PTN valuation assessment from Canaccord. Oh the humanity. LOL
If favorable Phase 3 data then pps will shoot much higher than $6 IMO. BTW, highly recommend reviewing the very large Phase 2 data to understand how successful it was. Do your own diligence and highly recommend not following the "sux to be them" bashers here. For me the most laughable thing is how they just keep blatantly deceiving and bashing while pretending they are true investors. Its like dude(s) u were outed long ago. Guess that gov't assistance check just doesn't cut it so penny a post is better than nuttin, eh. They are so lucky their boss doesn't require their posts be believable.
All weekend hammering and yammering. No cash. Phase 3 delays. Fewer sites. All bull hockey folks.
PTN press release this morning very simple: Phase 3 ahead of 50% enrollment. Enrollment to complete in 4th Qtr this year.
The game has changed since the Richter deal and Female Sexual Dysfunction has finally progressed with an approved drug. So my guess is that Richter was not the preferred partner profile anymore nor a large enough partner given the new worldwide metrics and market size for a Female Viagra.
yawns will leave out Brems huge positives: The drug works; Hugely successful very large phase 2 trial; the large Phase 3 is on track and not delayed; and now there is actually potential for a larger big pharma to replace the smaller Richter; Everything changed when A) SPROUT Drug was approved and validated the FSD market and B) Everything changed when SPROUT bought next day for $1Bil.
Anyway who u gonna believe the clowns - yawnie ray and kingy or one of the top biotech funds on wallstreet Baker Bros.